https://pinboard.in/u:Michael.Massing/public/ recent bookmarks from Michael.Massing 2026-02-05T04:16:07+00:00 https://www.medpagetoday.com/infectiousdisease/rsv/119744?xid=nl_mpt_DHE_2026-02-04&mh=7beedf85be02817127aebdf9dcc93d42&zdee=gAAAAABm4vYY3ATH4iFowacPbWxqKDu5cITUhZkLc-pWE7cJHyZXCk0IubgPcT3ehIWBv65TRh84YLvoUjk40DTyydSFRhNuf3hQ3R9bIlV4bQAMMvQuEGs%253D Michael.Massingrisk cardiovascular cardiorespiratory stroke heart attack infarct MCI myocardial RSV vaccine infarction research human clnical trial ln vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:bae1dde3e7f8/ 2024-09-23T03:20:00+00:00 https://www.nytimes.com/2024/09/18/well/cancer-infections-vaccines-treatments.html Michael.Massingcancer viruses infection correlation causation risk factor cause virus bacteria https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:be0cd3d01fe2/ 2024-08-13T04:50:31+00:00 https://www.medpagetoday.com/neurology/dementia/111479?xid=nl_mpt_DHE_2024-08-12&mh=7beedf85be02817127aebdf9dcc93d42 Michael.Massingdiet dementia foods risk anti-inflammatory pro-inflammatory correlation human in vivo clinical trial https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:44a259c828ae/ 2023-12-30T22:38:45+00:00 https://www.nytimes.com/2023/04/04/well/eat/tofu-health-benefits.html?action=click&pgtype=Article&state=default&module=styln-ask-well&variant=show&region=BELOW_MAIN_CONTENT&block=storyline_flex_guide_recirc Michael.Massing soy nutrition diet risk benefit heart disease cardiovascular cancer mortality isoflavones https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:849e6139d686/ 2023-11-15T20:21:39+00:00 https://9to5mac.com/2023/11/14/withings-launches-body-pro-2-diabetes-detection/ Michael.Massinghealth gadgets devices monitor risk diabetes diabetic complications scale feet https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:e9ce0051cdc1/ 2023-10-12T19:23:22+00:00 https://www.wsws.org/en/articles/2023/10/10/covi-o10.html Michael.Massingclinical cohort COVID19 human in mortality heart cardiovascular arteries plaque research retrospective risk treatment vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:eda87666376a/ 2023-10-12T18:48:13+00:00 https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(23)00235-3/fulltext#%20 Michael.MassingCOVID19 mortality risk treatment Paxlovid clinical research in vivo human retrospective cohort https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:75dcd7afbe3b/ 2023-06-07T05:27:02+00:00 https://www.nytimes.com/article/air-quality-index.html?name=styln-wildfires-smoke&region=TOP_BANNER&block=storyline_menu_recirc&action=click&pgtype=LegacyCollection&variant=undefined Michael.Massingair pollution quality index AQI risk mitigation https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:68180dd61f99/ 2023-06-03T01:08:49+00:00 https://www.washingtonpost.com/news/wonk/wp/2015/05/14/the-safest-and-deadliest-ways-to-travel/ Michael.Massinglong-distance travel relative risk fatality death mode transportation statistics https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:a5a4afca7e83/ 2023-06-03T01:05:23+00:00 https://turbli.com/blog/the-safest-transport-modes-ranked-by-statistics-from-10-years-of-data/ Michael.Massinglong-distance travel relative risk fatality death mode transportation statistics https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:be0d18cdbe17/ 2023-05-22T03:57:20+00:00 https://www.wired.com/story/aging-brain-volume/ Michael.Massing brain cardiovascular health risk benefit lifestyle culture BMI cholesterol blood lipids comparative physiology metabolism https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:e22e31e80619/ 2023-04-29T18:28:09+00:00 https://www.google.com/search?client=safari&rls=en&q=%22Prediabetic%22+was+a+negotiated+label+for+failing+a+one+of+two+oral+glucose+tolerance+tests#ip=1 Michael.Massingdiabetes type 2 T2D diagnosis threshold morbidity mortality comorbidity risk overview criticism standard https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:7e811b2f162f/ 2023-04-07T22:15:39+00:00 https://medicalxpress.com/news/2023-04-diabetes.html Michael.Massingdiabetes type 2 research peer-reviewed human in vivo clinical situ screening prevention delay risk factor https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:a1b2761cabcb/ 2023-03-28T21:50:07+00:00 https://www.sflorg.com/2023/03/bio03282302.html Michael.Massingtype 2 diabetes T2D insulin resistance fat dietary adipose tissue pathophysiology risk factor etiology diet behavior behavioral environment environmental obesity endocrine body https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:77e14458fb43/ 2023-03-24T15:02:04+00:00 https://www.levelshealth.com/blog/do-you-get-enough-zinc-heres-how-it-benefits-metabolic-health Michael.Massing T2D pancreas beta cells wound healing zinc dosage overview risk benefit systemic effects diabetes type 2 interactions food sources blood levels https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:9be1798c8cda/ 2023-01-10T17:15:30+00:00 https://www.rush.edu/news/understanding-link-between-covid-19-and-diabetes Michael.Massing diabetes etiology cause risk factors type 1 2 T1D T2D autoimmune hyperinflammation prediabetes inflammation subclinical overview resarch long COVID post-acute sequelae liver hybrid insulin resistance immune system steroids pancreatitis pancreas metabolic stress https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:6fbe3726f6ad/ 2022-12-26T01:59:34+00:00 https://www.medrxiv.org/content/10.1101/2022.12.21.22283753v1 Michael.Massing metformin preprint research clinical trial risk comparison human in vivo randomized phase 3 https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:4c72b7923adf/ 2022-12-20T19:50:31+00:00 https://www.diabetesselfmanagement.com/news-research/2022/12/14/a1c-testing-may-help-detect-undiagnosed-diabetes/ Michael.Massing diabetes diagnosis screening A1c BMI age risk validated score undiagnosed https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:9c5a8ebc62b3/ 2022-10-04T04:02:48+00:00 https://www.webmd.com/diet/ss/slideshow-zinc-mineral?ecd=wnl_spr_042122_remail&ctr=wnl-spr-042122-remail_lead_cta&mb=WlcCxCEv%408g239bDT2bGdeHnVev1imbCLJvzB2ihRmM%3D Michael.Massing Zinc food foods supplements risk benefit https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:a342ba304879/ 2022-08-28T19:13:48+00:00 https://www.medpagetoday.com/opinion/second-opinions/100409?xid=nl_secondopinion_2022-08-28&eun=g894600d0r Michael.Massing obesity health correlation comorbidities risk population race racial ethnic disparities gender sex care malnutrition https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:f09dc7f82dea/ 2022-04-08T02:24:59+00:00 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587545/ Michael.Massingdeterioration worsening diabetic retinopathy risk benefit human in vivo research peer-reviewed rapid improvement glucose control A1c review https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:4109b06e318f/ 2022-03-26T18:35:18+00:00 https://www.medpagetoday.com/neurology/dementia/97854?xid=nl_covidupdate_2022-03-25&eun=g894600d0r Michael.Massing0.05). Future development of Alzheimer's dementia was progressively higher and likely to occur earlier among people who had blood glucose in pre-diabetic (100 to 126 mg/dL) and diabetic (>126 mg/dL) ranges in early adulthood and middle adulthood. "Intervention targeting cholesterol and glucose management starting in early adulthood can help maximize cognitive health in later life," Farrer suggested.]]> Framingham longitudinal data risk Alzheimer's cardiovascular factors peer-reviewed research HDL high-density lipoprotein correlation cohort human in vivo prospective trial prevention intervention https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:1b2481ed6811/ 2021-12-16T03:23:08+00:00 https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwab189/6447088 Michael.Massing40%. Importantly, in this first and largest meta-analysis reviewing LVEF >50%, we show that this benefit is maintained, albeit to a lesser degree, in the cohort of patients with LVEF ≥50%. SGLT2i become in this way the first medication with potential for prognostic benefit in HFpEF. However, overall mortality was not improved in HFpEF, indicating that the other comorbidities associated with HFpEF play a significant role. In order to draw robust conclusions safely regarding these efficacy outcomes, further large trials need to evaluate the effect of the SGLT2 inhibitors in a sufficient number of patients with HFpEF. The various subphenotypes of HFpEF and its management have puzzled physicians for several years. The high rates of morbidity and mortality that it carries, along with the diagnostic and treatment challenges, have transformed it in one of the most challenging clinical entities. SGLT2i appear to provide some light and positivity, as their cardiometabolic profile impacts favourably on the complex pathophysiological mechanisms involved in HFpEF.9 However, the quest to untangle the complexity of treating HFpEF is certainly not over. We show conclusively that for LVEF 40–50% included as HFpEF in previous studies (but no longer considered HFpEF in the guidelines) there is a strong benefit from SGLT2i translating to reduced cardiovascular mortality and HHF, but not overall mortality. This also extended to the LVEF >50% but with a smaller effect. Additionally, while the vast majority of the patients included in this meta-analysis were individuals with diabetes at baseline, the cardioprotective benefits of the SGLT2i have been shown to occur via mechanisms independent of baseline diabetes status.10 Furthermore, the effect of SGLT2i in patients with reduced EF without diabetes is well-documented9,10 and EMPEROR-Preserved also included patients without diabetes, therefore their effect is applicable to patients without diabetes.]]> SGLT2 inhibitor risk benefit heart failure ejection fraction meta-analysis diabetes comorbidity cardiac cardiovascular protection peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:c3be4a0be53b/ 2021-12-15T15:51:01+00:00 https://khn.org/news/article/rural-hospital-closures-georgia/ Michael.MassingMedicaid expansion morbidity mortality risk obstructionism diagnosis treatment health disparities cost benefit poverty SDH social determinants of epidemiology correlation chronic population obstruction public disease burden access care healthcare rural hospitals research data sources https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:582a9185ac41/ 2021-12-13T02:46:13+00:00 https://www.medpagetoday.com/primarycare/sleepdisorders/96030?xid=nl_mpt_DHE_2021-12-12&eun=g894600d0r Michael.Massingcannabis sleep risk benefit THC CBD obstructive apnea OSA peer-reviewed research human trial retrospective recall https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:3198bd478de6/ 2021-12-01T04:12:01+00:00 https://academic.oup.com/ajcn/article/93/5/1062/4597729 Michael.Massing diet study clinical research in vivo human low carb carbohydrate high protein weight fat loss maintenance benefit risk keto peer-reviewed crossover https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:c7ae6abdda0e/ 2021-10-25T01:20:04+00:00 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02188-7/fulltext Michael.Massing insulin glargine GIP GLP-1 receptor A1c Hb hemoglobin benefit risk cardiovascular peer-reviewed research clinical trial human in vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:eb3838f4fd08/ 2021-10-24T22:37:12+00:00 https://heart.bmj.com/content/early/2021/10/13/heartjnl-2021-319672 Michael.Massing atrial fibrillation treatment options risk benefit cardiovasculr cohort study peer-reviewed research human retrospective https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:2670b7dfdf20/ 2021-10-06T03:12:26+00:00 https://www.mdpi.com/2072-6643/13/10/3299/htm#B94-nutrients-13-03299 Michael.Massing low carbohydrate diet carb dietary guidelines for Americans DGA insulin resistance metabolic syndrome risk benefit peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:9aabcf072568/ 2021-09-26T02:36:30+00:00 https://www.uptodate.com/contents/pneumococcal-vaccination-in-adults Michael.Massing pneumonia vaccination pneumococcal disease aging risk benefit prevalence incidence guidelines peer-reviewed research overview human in vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:3c489e81785e/ 2021-09-21T02:51:49+00:00 https://www.endocrinologyadvisor.com/home/topics/diabetes/increased-risk-for-major-adverse-cardiovascular-events-with-insulin-in-patients-with-diabetes-and-acs/?NID=-1&cpn&email_hash=983917dd1eba78eb44e393fea65df5ca&hmEmail=Jw_YJjhVyI84iX-Oepu7iw7YiNSIB0EK31LP7LVx8w01&hmSubId=YY-zPItNrOw1&mpweb=1323-153862-7624403 Michael.Massingtreatment risk benefit insulin cardiovascular heart ACS acute coronary syndome peer-reviewed research in vivo human clinical trial https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:d28499eda07c/ 2021-09-16T22:50:01+00:00 https://www.diabetesprevention.pitt.edu/for-the-public/diabetes-prevention-program-dpp/ Michael.Massing diabetes type 2 T2D prevention intervention behavioral diet exercise activity weight fat loss body risk factors in vivo human clinical trial situ support treatment progression management resource information education https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:a3fdd5e0649f/ 2021-08-25T17:28:16+00:00 https://www.endocrinologyadvisor.com/home/topics/diabetes/type-2-diabetes/weight-loss-and-cardiovascular-renal-benefit-with-sglt2-inhibitors-in-t2d/?hmSubId=YY-zPItNrOw1&hmEmail=Jw_YJjhVyI84iX-Oepu7iw7YiNSIB0EK31LP7LVx8w01&NID=-1&email_hash=983917dd1eba78eb44e393fea65df5ca&mpweb=1323-149900-7624403 Michael.Massing SGLT2 inhibitors peer-reviewed research human clinical trial review in vivo situ risk benefit diabetes treatment T2D type 2 kidney heart cardiovascular CVD genital infection necrosis diabetic ketoacidosis DKA https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:253b12fb0e87/ 2021-06-15T02:35:07+00:00 https://www.diabetes.org/a1c/diagnosis Michael.Massingdiabetes diagnostic diagnosis standard threshold glycated hemoglobin A1c HbA1c prediabetes normal risk blood glucose test random fasting sugar oral tolerance ADA https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:0622d36d39d2/ 2021-06-15T02:11:56+00:00 https://www.mayoclinic.org/diseases-conditions/diabetes/diagnosis-treatment/drc-20371451 Michael.Massing diabetes diagnostic diagnosis standard threshold glycated hemoglobin A1c HbA1c prediabetes normal risk blood glucose test random fasting sugar oral tolerance Mayo Clinic https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:fc2a14081741/ 2021-05-29T00:15:11+00:00 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664031/ Michael.Massing turmeric piperine drug interacton elimination benefit risk potential overview supplement spices dose dosage adverse effects review peer-reviewed research clinical human in vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:b86b1b6c9f15/ 2021-05-29T00:11:46+00:00 https://www.nbcnews.com/better/health/health-benefits-turmeric-it-s-complicated-ncna792901 Michael.Massing turmeric piperine drug interacton elimination benefit risk potential overview supplement spices https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:0186d1f0fbc7/ 2021-05-06T00:36:48+00:00 https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/expert-answers/blood-sugar/faq-20057941#:~:text=The%20average%20U.S.%20adult%20drinks,day%20appears%20to%20be%20safe. Michael.Massing coffee caffeine blood sugar glucose fluctuation correlation variability sensitivity insulin overview risk benefit human research in vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:533973f62425/ 2021-05-06T00:33:53+00:00 https://www.webmd.com/diabetes/diabetes-and-caffeine Michael.Massing coffee caffeine blood sugar glucose fluctuation correlation variability sensitivity insulin peer-reviewed research human in vivo randomized controlled trial RCT crossover risk benefit https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:9750fdff7305/ 2021-05-06T00:32:33+00:00 https://care.diabetesjournals.org/content/27/12/2990 Michael.Massing coffee caffeine blood sugar glucose fluctuation correlation variability sensitivity insulin peer-reviewed research human in vivo randomized controlled trial RCT crossover risk benefit https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:dfb72525ee30/ 2021-05-06T00:27:04+00:00 https://www.healthline.com/health/coffee-s-effect-diabetes#other-benefits Michael.Massing coffee caffeine blood sugar glucose fluctuation correlation variability risk benefit human research in vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:f8637efd721d/ 2021-05-06T00:23:30+00:00 https://www.everydayhealth.com/type-2-diabetes/symptoms/surprising-causes-of-blood-sugar-swings/ Michael.Massing coffee caffeine blood sugar glucose fluctuation correlation risk benefit human research in vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:5a64e473f0b2/ 2021-05-01T01:23:31+00:00 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544578/ Michael.Massingcoffee glucose metabolism risk benefit systematic review in vivo clinical trials human peer-reviewed research caffeine insulin resistance sensitivity https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:f56677ae5aa2/ 2021-03-28T00:49:12+00:00 https://scholar.google.com/scholar?hl=en&as_sdt=0%2C7&as_vis=1&q=whole+grains+longevity+cardiovascular+cardiac+risk&btnG= Michael.Massing whole grains longevity cardiovascular cardiac risk benefit protection diet food foods https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:100c845abbb9/ 2021-02-13T21:44:33+00:00 https://www.aarp.org/caregiving/health/info-2021/nursing-homes-minorities-covid-deaths.html Michael.Massing population institutionalization long term care race racism structural research human aging health healthcare prevention pandemic risk factors ethnicity Medicaid expansion obstruction obstructionism morbidity mortality https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:d52efc4b8bec/ 2021-01-10T17:21:17+00:00 https://www.medpagetoday.com/infectiousdisease/covid19/90569 Michael.Massing comorbidities risk factor age aging COVID19 treatment therapy convalescent plasma peer-reviewed research random placebo progression early intervention clinical trial in vivo human situ NNT reduction https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:1d73e3c064d3/ 2020-10-15T06:30:28+00:00 https://link.springer.com/article/10.1007/s00125-020-05253-x#Sec4 Michael.Massingdiabetes type 2 risk factors T2D correlation peer-reviewed research epidemiology etiology https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:5ebc949a473c/ 2020-09-27T17:44:12+00:00 https://care.diabetesjournals.org/content/28/11/2756 Michael.Massing FBG IFG impaired fasting blood glucose mortality CVD cardiovascular disease risk threshold diagnostic standards prediabetes diabetes all-cause peer-reviewed research in vivo human cohort study https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:117b43629584/ 2020-09-21T07:59:58+00:00 https://www.medpagetoday.org/infectiousdisease/uritheflu/88447?xid=nl_mpt_DHE_2020-09-04&eun=g894600d0r&vpass=1 Michael.Massing influenza flu cardiovascular risk events human retrospective in vivo cross-sectional peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:bfcd7be5b46b/ 2020-09-21T06:00:41+00:00 https://academic.oup.com/eurheartj/article/41/32/3038/5901158 Michael.Massing COVID19 COVID endothelial cardiovascular heart brain kidneys risk morbidity mortality https://twitter.com/ https://pinboard.in/u:Michael.Massing/b:6e7a6923a604/ 2020-09-20T07:32:28+00:00 https://www.google.com/search?newwindow=1&client=safari&rls=en&sxsrf=ALeKk00DhLsxFCDJMbebcbFW-TZc-k2Tzw%3A1600586672296&ei=sANnX6_VEcmc_Qbzm5uoBw&q=polio+scare+swimming+pools+1950s+50s+1956&oq=polio+scare+swimming+pools+1950s+50s+1956&gs_lcp=CgZwc3ktYWIQAzoECAAQRzoFCCEQoAFQ3OgFWJT5BWD3ggZoAHABeACAAboBiAG1BJIBAzMuMpgBAKABAaoBB2d3cy13aXrIAQjAAQE&sclient=psy-ab&ved=0ahUKEwiv7aKAmvfrAhVJTt8KHfPNBnUQ4dUDCAw&uact=5 Michael.Massingpolio scare postwar 50s 1950s 1956 epidemic outbreak risk public health https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:7138d5f5cd6f/ 2020-04-04T15:26:20+00:00 https://www.medpagetoday.com/primarycare/dietnutrition/82492 Michael.Massingmeat diet risk processed evidence assessment meta-analysis systematic review https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:385fe8192571/ 2020-04-04T15:18:28+00:00 https://www.medpagetoday.com/endocrinology/type1diabetes/82755?xid=nl_mpt_DHE_2019-10-16&eun=g894600d0r Michael.Massing islet transplantation transplant pancreas T1D type 1 diabetes glycemic control blood glucose Edmonton protocol hypoglycemia unawareness kidney risk https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:29fec18ec123/ 2020-02-05T02:34:38+00:00 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2628970 Michael.Massingtobacco risk nicotine toxicology peer-reviewed research delivery system heated product heat-not-burn https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:47b29a56847a/ 2020-02-05T02:32:42+00:00 https://www.cdc.gov/tobacco/data_statistics/ Michael.Massingsecondhand smoke CDC risk data statistics smoking tobacco nicotine public health vaping https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:64a2e78c97c2/ 2020-02-05T02:31:23+00:00 https://www.hhs.gov/sites/default/files/consequences-smoking-consumer-guide.pdf Michael.Massingsecondhand smoke Surgeon General HHS risk toxicology peer-reviewed research smoking tobacco nicotine public health https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:cd25f56c2b7a/ 2020-02-05T02:30:12+00:00 https://www.bloomberg.com/news/articles/2019-09-25/vaping-illness-signs-were-missed-or-ignored Michael.Massingrisk vaping tobacco science public health nicotine https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:d005386c3760/ 2020-02-05T02:29:05+00:00 https://www.cdc.gov/tobacco/data_statistics/fact_sheets/secondhand_smoke/index.htm Michael.Massingsecondhand smoke HHS risk toxicology peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:e3de0b3ec295/ 2020-02-05T01:36:55+00:00 https://www.ncbi.nlm.nih.gov/books/NBK44314/ Michael.Massingsecondhand smoke Surgeon General HHS risk toxicology peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:3c744a08a6b0/ 2020-02-05T01:36:32+00:00 https://www.ncbi.nlm.nih.gov/books/NBK44323/ Michael.Massingsecondhand smoke Surgeon General HHS risk toxicology peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:a620ec968e55/ 2020-02-05T01:35:53+00:00 https://www.ncbi.nlm.nih.gov/pubmed/20669524 Michael.Massingsecondhand smoke Surgeon General HHS risk https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:5ffdfdec8e19/ 2020-01-11T22:24:45+00:00 https://www.who.int/tobacco/publications/prod_regulation/heated-tobacco-products/en/ Michael.Massingtobacco HTP risk benefit research fact sheet WHO https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:a2bdfcfb235b/ 2020-01-11T21:55:21+00:00 https://www.cdc.gov/tobacco/basic_information/e-cigarettes/pdfs/Electronic-Cigarettes-Infographic-508.pdf?s_cid=bb-osh-effects-graphic-007 Michael.Massingtobacco public health risk benefit e-cigarettes FDA https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:8e2982714f2e/ 2020-01-11T20:58:36+00:00 https://tobaccocontrol.bmj.com/content/tobaccocontrol/27/Suppl_1/s1.full.pdf Michael.MassingHTP tobacco public health risk product FDA PMI IQOS international marketing addiction science criticism peer-reviewed research behavioral biological https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:ae0418ed10b5/ 2020-01-11T20:39:12+00:00 https://www.who.int/tobacco/publications/prod_regulation/htps-marketing-monitoring/en/ Michael.Massingtobacco youth advertising prevalence use risk marketing WHO HTP https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:ad92860af736/ 2020-01-11T20:33:23+00:00 https://www.cdc.gov/tobacco/infographics/youth/index.htm Michael.Massing tobacco youth advertising e-cigarettes prevalence use risk https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:25aa5afb6e86/ 2020-01-11T19:15:11+00:00 https://tobaccocontrol.bmj.com/content/27/Suppl_1#Researchpapers Michael.Massing HTP tobacco public health risk product international marketing addiction science criticism peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:052bcb2082c0/ 2020-01-11T18:28:31+00:00 https://tobaccocontrol.bmj.com/content/27/Suppl_1/s7 Michael.Massing HTP tobacco public health risk regulation product development approval international marketing addiction https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:66d6e4241668/ 2020-01-11T14:19:28+00:00 https://tobacco.ucsf.edu/pmi-using-fda-sell-iqos-outside-us Michael.MassingPMI HTP tobacco public health FDA risk regulation product development approval international marketing authorization https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:0199fb8fcad4/ 2020-01-11T13:53:05+00:00 https://www.pmi.com/resources/docs/default-source/pmi-innovation/scientific-update-issue-5-june-2018.pdf?sfvrsn=8bfe99b5_4 Michael.MassingHTP tobacco public health FDA risk regulation product development PMI approval https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:01c734c540db/